Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
FDA nonclinical toxicology review (2023-2024) flagged DNA damage in pituitary cells and injection-site necrosis in animal studies, plus immunogenicity and impurity risks from compounded material, alongside GH/IGF-1-axis effects such as fluid retention, joint discomfort, flushing, and headache reported by users
Overview SLU-PP-332 500mcg (30mL) is a synthetic research compound referenced in emerging scientific and preclinical literature for the study of metabolic regulation, cellular energy balance, and pathway-specific signaling within controlled laboratory environments
Independent concentration verification
Cyanocobalamin (Vitamin B12)..............5000 mcg Benzyl Alcohol (preservative).................1.0% v/v Sodium Chloride.................................0.22% w/v Ammonium Sulfate...............................0.1% w/v Citric Acid..........................................0.01% w/v Sodium Citrate..................................0.008% w/v Inject subcutaneously or intramuscularly
As more research is conducted, the potential for FDA approval of these therapies may increase, but in the meantime, peptides like BPC 157 offer an exciting option for those looking to accelerate healing and improve their quality of life
US$ 20.45
US$ 26.97
US$ 21.10
US$ 27.15
US$ 21.83
US$ 21.71
US$ 24.56
US$ 23.39
US$ 24.01
